PET/CT in the Imaging of CNS Tumors.

IF 4.6 2区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Seminars in nuclear medicine Pub Date : 2025-05-21 DOI:10.1053/j.semnuclmed.2025.04.002

Katarzyna Barańska, Katarzyna Niemas, Kacper Pełka, Jolanta Kunikowska

引用次数: 0

Abstract

Central nervous system (CNS) tumors are quite rare but cause significant morbidity and mortality. Positron Emission Tomography (PET) is a widely utilized imaging modality within the field of nuclear medicine. CNS tumor diagnostics are an essential tool in the diagnosis and treatment of patients with glioma, offering valuable insights into tumor characteristics, treatment response and outcomes. A variety of different tracers are used in PET imaging of brain tumors including ¹⁸F-labeled fluorodeoxyglucose ([¹⁸F]FDG), markers showing amino acid metabolism, angiogenesis or inflammatory processes. In this article we describe possibility of use different tracers in different clinical scenario of CNS tumors.

查看原文本刊更多论文

PET/CT在中枢神经系统肿瘤成像中的应用。

中枢神经系统（CNS）肿瘤非常罕见，但发病率和死亡率很高。正电子发射断层扫描（PET）是核医学领域中广泛应用的成像方式。中枢神经系统肿瘤诊断是胶质瘤患者诊断和治疗的重要工具，为肿瘤特征、治疗反应和结果提供了有价值的见解。多种不同的示踪剂用于脑肿瘤的PET成像，包括18F标记的氟脱氧葡萄糖（[18F]FDG），显示氨基酸代谢，血管生成或炎症过程的标记物。在本文中，我们描述了在中枢神经系统肿瘤的不同临床情况下使用不同示踪剂的可能性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Seminars in nuclear medicine 医学-核医学

CiteScore

9.80

自引率

6.10%

发文量

审稿时长

14 days

期刊介绍： Seminars in Nuclear Medicine is the leading review journal in nuclear medicine. Each issue brings you expert reviews and commentary on a single topic as selected by the Editors. The journal contains extensive coverage of the field of nuclear medicine, including PET, SPECT, and other molecular imaging studies, and related imaging studies. Full-color illustrations are used throughout to highlight important findings. Seminars is included in PubMed/Medline, Thomson/ISI, and other major scientific indexes.